- Quick navigation
- Home
- Open menu
- Page content
- Customer service
- Search
- Footer
IBSA Group
IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 Countries on 5 continents, through the Company’s 20 subsidiaries located in Europe, China, and the United States.
The company has a consolidated turnover of 986 million CHF and employs over 2,300 people between headquarters, subsidiaries and production sites. IBSA holds 90 families of approved patents, plus others under development, as well as a vast portfolio of products, covering 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gynaecology, cardiometabolic, respiratory, consumer health. It is also one of the largest operators worldwide in the area of reproductive medicine, and one of the world’s leaders in hyaluronic acid-based products. IBSA has based its philosophy on four pillars: Person, Innovation, Quality and Responsibility.
Gallery (4)
Multimedia (1)
Opening times
- Monday8:00 to 18:00
- Tuesday8:00 to 18:00
- Wednesday8:00 to 18:00
- Thursday8:00 to 18:00
- Friday8:00 to 18:00
- SaturdayClosed
- SundayClosed
Rating 5 of 5 stars
Opening times
- Monday8:00 to 18:00
- Tuesday8:00 to 18:00
- Wednesday8:00 to 18:00
- Thursday8:00 to 18:00
- Friday8:00 to 18:00
- SaturdayClosed
- SundayClosed
- Telephone:
- Website:
Reviews for IBSA Institut Biochimique SA
- English,French,German,Italian
- Close to public transport,Parking site
- Categories
- Pharmaceutical products, servicesReproductive medicineEndocrinology-diabetologyAesthetic medicineUrologyLaboratoryCosmetic productsDoctors
Languages
Location
Services

Aesthetic Medicine
Aesthetic medicine aims to improve and maintain the aesthetic well-being of the skin, through a precise analysis of the general and local conditions of the patient, the formulation of accurate diagnoses and the development of therapeutic strategies.
IBSA offers a complete range of products based on the concept of Hydrolift® Action, an innovative approach aimed at counteracting the physiological decrease of the hyaluronic acid (HA) naturally present in the skin, thus restoring its hydration, elasticity and tone.
In recent years, the line has been expanded with an innovative product containing a solution of thermally stabilised ultrapure hyaluronic acid hybrid cooperative complexes developed with IBSA’s patented hybrid Nahyco® technology.
PriceOn request

Pain and Inflammation
Across Europe, around 500 million working days are lost each year due to chronic and acute pain, resulting in a huge social and economic impact.
Among the different remedies available for the symptomatic treatment of pain, non-steroidal anti-inflammatory drugs (NSAIDs) have been, and still are, widely used.
In the area of pain and inflammation, IBSA offers various types of products for topical, oral and transdermal use.
PriceOn request

Endocrinology
Hypothyroidism is one of the most common chronic disorders, affecting up to 5% of the global population and requiring thyroid hormone replacement therapy.
For the treatment of hypothyroidism, IBSA developed innovative liquid and soft capsule formulations of hormones and supplements.
PriceOn request

Uro-gynaecology
Patients with recurrent Urinary Tract Infections (rUTI), Interstitial Cystitis (IC/BPS), or cystitis from radiotherapy or chemotherapy suffer from urothelial damage, which causes severe pain and inflammation.
IBSA offers several types of hyaluronic acid-based products in pre-filled syringes and soft capsules that help prevent damage to the urothelium, while improving its healing process. The company also focuses on male disorders, such as Erectile Dysfunction (ED), with the innovative oral formulation in orodispersible film (ODF).
PriceOn request

Cardiometabolic
In the last two decades, interest in omega-3 Polyunsaturated Fatty Acids (PUFA) has grown, thanks to their antidyslipidemic, anti-inflammatory, antiarrhythmic and antithrombotic properties.
In addition to being introduced in the diet, omega-3s, extracted from fish oil, can be prescribed by doctors as drugs in case of certain chronic conditions. IBSA uses omega-3 fatty acids (EPA/DHA), which have been certified as a sustainable source by the NGO Friends of the Sea and have obtained the IFOS Five Star certification for their purity, freshness and concentration.
PriceOn request

Dermatology
Within the dermatological area, IBSA developed a portfolio of hyaluronic acid-based products obtained through a patented and certified bio-fermentation process.
The line of hyaluronic acid-based products is completed by cosmetic products (a spray and a gel formulation) indicated for skin irritations of various origins (wind, sun, cold, sweat, shaving, beauty treatments and tattoos).
PriceOn request

Consumer Health
In the Consumer Health area, IBSA has developed several solutions to better address the small challenges to which the body is exposed every day.
PriceOn request

Respiratory
In terms of mortality, incidence and costs, respiratory diseases are second only to cardiovascular conditions.
Globally, hundreds of millions of people suffer from chronic respiratory diseases. Climate change is probably responsible for several negative effects on our health, as described by WHO.
In Europe and in the rest of the world, mortality from chronic respiratory and lung diseases is expected to increase in the future. IBSA offers a range of mucolytics and other products containing hyaluronic acid, indicated as an adjuvant treatment for several chronic conditions.
PriceOn request

Reproductive Medicine
Infertility is a female and male disease defined by the inability to achieve pregnancy after 12 months or more of regular sexual intercourse.
Approximately 17.5% of the adult population, or one in six people worldwide, suffer from infertility, highlighting the urgent need to increase access to fertility care (WHO).
Infertility, therefore, has an undeniable social dimension and cannot be relegated, as is often the case, to a minority of couples left to address their issues alone. IBSA is one of the major players within reproductive medicine, offering a portfolio of products for the treatment of infertility, including progesterone in aqueous solution and extractive gonadotropins, which are highly glycosylated thanks to a unique purification process.
PriceOn request

Osteoarticular
Osteoarticular conditions – which affect about 10% of the world population – occur in two forms: inflammatory and degenerative.
They are usually characterised by a chronic evolution which, if left untreated, can lead to irreversible damage to the joint structures, leading to disability and invalidity.
In the osteoarticular area, IBSA offers several types of products, to be taken orally or intra-articularly.
PriceOn request

